Conditions: Community Acquired Pneumonia (CAP)
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 102
Healthy volunteers: no

Brief summary:
Azithromycin has high rates of clinical response and eradication, wide spectrum of activity, so we suppose the development of the azithromycin injectable formulation in Japan would deliver benefit to patients of community acquired pneumonia.

Detailed description:

Arms:
arm 1: Azithromycin switch therapy (switch from intravenous to oral)

Interventions: intervention 1: Azithromycin
Intervention descriptions: intervention 1: The intravenous formulation 500 mg is administered once daily for 2-5 days; followed by the oral formulation 500 mg will be given once daily to complete a 7 to 10-day course of therapy.

Protocol document: